Tirzepatide and semaglutide are both highly effective for the management of obesity. How the two drugs compare in patients with obesity but without diabetes has been unknown.
Research findings from the SURMOUNT-5 phase 3b trial are summarized in a short video. nej.md/3GqiRm0
ALT An illustration of a patient with obesity but without diabetes in the center with tirzepatide on the left and semaglutide on the right.
Delighted to be supporting the launch of UKCPO tonight.
It's a testament to all the volunteers to see such a turnout and support tonight.
Best of luck to a fantastic team!
#UKCPOLaunch
Great session from @ECPObesity ❤️. @kenclare & team are the embodiment of what it means to be mission-driven. Learned so much from @susieb16 on the impact of stigmatising language and images over the years (that is still thoughtlessly used in intervention content and delivery)
#ECO2025 begins Sunday, 11th May in Malaga, 🇪🇸. Join more than 3500 delegates from across Europe and globally at the premier #obesity congress and meet fellow researchers, scientists and medical professionals.
@EASOobesityECN@EASOpresident@SociedadSeedo
Calling all researchers, clinicians and public health professionals! Abstract submissions for #UKCO2025 will close on the 6th May. This is a fantastic opportunity to share your research and contribute to the UK's leading obesity conference.
Submit here: buff.ly/9sDdCEm
Calling all researchers, clinicians and public health professionals! Abstract submissions for #UKCO2025 will close on the 6th May. This is a fantastic opportunity to share your research and contribute to the UK's leading obesity conference.
Submit here: buff.ly/9sDdCEm
Both really great awards. Still feels unusual to see something named after me. I have seen lots of amazing PPI/E work this year so get applying. @UK_ASO@bariatricBOMSS @ObesityInst @ECPObesity
Apply for two prestigious awards when submitting your #UKCO2025 abstract here: bit.ly/3XjwtoD
⭐️ Best Practice Award – For research with real-world impact
⭐️ Ken Clare Award – For outstanding patient & public engagement